supplement
penicillin
uml
streptomycin
fungizon
ftgml
fetal
bovin
serum
fb
heat
inactiv
rain
primari
rabbit
kidney
prk
cell
maintain
mem
fb
tri
abuff
salin
tri
ph
contain
mm
mm
kci
mm
tri
hsa
tri
aedta
tri
mm
edta
tri
acm
tri
mm
ca
mm
mg
viru
prepar
herp
simplex
viru
type
adenoviru
type
simian
foami
viru
type
propag
assay
prk
cell
influenza
viru
type
parainfluensa
viru
type
sendal
propag
assay
inocul
allanto
fluid
embryon
hen
egg
viru
pool
uninfect
prk
cell
control
allanto
fluid
centrifug
rpm
rain
remov
cell
debri
supernat
fluid
centrifug
rpm
h
pellet
resuspend
dulbecco
phosphatebuff
salin
pb
origin
volum
singl
viru
pool
contain
follow
titer
use
throughout
studi
plaqueform
unit
pfu
ml
tissu
cultur
infecti
dosesso
tcidso
ml
x
e
tcidml
influenza
egg
infecti
dosesso
eidso
ml
sendai
eidoml
leukocyt
prepar
human
peripher
blood
mix
ml
dextran
dextran
wtvol
salin
abbott
laboratori
north
chicago
ill
supplement
ml
glucos
ml
edta
per
ml
blood
mixtur
allow
settl
room
temperatur
rain
leukocyterich
plasma
remov
cell
sediment
rpm
rain
suspend
tri
aedta
remov
red
blood
cell
accomplish
hypoton
shock
sequenti
wash
tri
aedta
rpmi
medium
leukocyt
resuspend
rpmi
medium
contain
fb
histamin
releas
reaction
leukocyt
suspens
contain
x
cell
ml
incub
either
equal
volum
infecti
viru
equival
amount
uvinactiv
viru
appropri
control
media
except
state
viru
cell
ratio
express
multipl
infect
moi
use
incub
co
atmospher
h
cell
wash
resuspend
rpmi
medium
incub
addit
h
experi
perform
least
twice
experi
reaction
set
duplic
control
consist
media
uninfect
prk
cell
allanto
fluid
prepar
dilut
manner
viru
pool
end
incub
period
leukocyt
sediment
centrifug
rpm
rain
supernat
fluid
save
histamin
assay
interferon
titrat
cell
wash
tri
resuspend
appropri
amount
tri
acm
duplic
cell
sampl
ml
vol
incub
equal
volum
serial
dilut
ragwe
antigen
e
antihuman
ige
air
min
tube
transfer
icebath
ml
cold
tri
acm
ad
cell
centrifug
rpm
min
supernat
fluid
assay
histamin
total
cellular
histamin
content
express
complet
determin
lysi
leukocyt
perchlor
acid
histamin
releas
supernat
fluid
blank
contain
cell
tri
acm
exceed
total
cellular
histamin
histamin
assay
histamin
assay
autom
fluorometr
techniqu
percent
histamin
releas
calcul
formula
releas
el
e
fluorometr
read
experiment
supern
mean
blank
mean
complet
data
analyz
either
standard
test
two
mean
pair
test
two
histamin
releas
curv
compar
interferon
assay
interferon
activ
supernat
fluid
leukocyt
cultur
assay
modif
micropl
method
develop
green
et
al
brief
monolay
wish
cell
micropl
incub
h
serial
twofold
dilut
interferon
sampl
vol
cell
challeng
pfu
vsv
end
h
viru
inoculum
remov
cell
wash
refe
ml
mem
supplement
fb
methylcellulos
h
cell
fix
ethanol
stain
giemsa
solut
viral
plaqu
count
interferon
titer
express
reciproc
highest
dilut
reduc
vsv
plaqu
count
initi
experi
design
see
whether
incub
virus
leukocyt
caus
releas
histamin
peripher
blood
leukocyt
obtain
allerg
nonallerg
human
donor
incub
influenza
moi
h
incub
atmospher
supernat
fluid
assay
histamin
content
seen
tabl
amount
histamin
releas
supernat
fluid
alter
addit
either
infecti
inactiv
virus
leukocyt
cultur
also
appreci
chang
cellular
histamin
content
data
shown
infecti
viru
leukocyt
incub
infecti
virus
control
media
h
challeng
antiig
min
amount
histamin
releas
supernat
fluid
determin
result
typic
experi
cell
one
individu
shown
fig
leukocyt
treat
show
enhanc
histamin
releas
expos
antiig
p
optimum
antiig
concentr
cell
cultur
control
media
releas
histamin
wherea
cell
cultur
releas
fig
similarli
leukocyt
incub
influenza
challeng
antiig
show
enhanc
histamin
releas
p
optimum
concentr
antiig
cell
treat
control
allant
fluid
releas
histamin
wherea
cell
treat
influenza
releas
histamin
fig
b
incub
cell
also
result
statist
signific
increas
histamin
releas
p
although
absolut
enhanc
pronounc
virus
challeng
differ
concentr
antiig
data
fig
show
leukocyt
incub
either
infecti
uvinactiv
viru
releas
significantli
histamin
leukocyt
expos
control
media
p
pair
test
reveal
signific
differ
curv
gener
infecti
vs
uvinactiv
viru
p
subsequ
histamin
releas
experi
uvinactiv
virus
use
see
increas
histamin
releas
due
activ
phagocytesi
leukocyt
incub
latex
bead
h
analysi
supernat
fluid
incub
leukocyt
antiig
fail
reveal
enhanc
histamin
releas
data
shown
doserespons
studi
relationship
concentr
viru
incub
leukocyt
result
increas
histamin
releas
shown
fig
signific
enhanc
histamin
releas
p
observ
ratio
viru
leukocyt
moi
greater
moi
signific
increas
histamin
releas
p
releas
interferon
activ
capac
virus
enhanc
histamin
releas
challeng
ragwe
antigen
e
antiig
test
leukocyt
differ
donor
data
tabl
ii
show
enhanc
histamin
releas
six
seven
donor
p
leukocyt
tim
seventh
donor
releas
high
amount
histamin
challeng
antiig
presenc
viru
result
enhanc
demonstr
infecti
uvinactiv
viru
enhanc
histamin
releas
indic
viral
replic
requir
rais
possibl
enhanc
might
immun
specif
studi
possibl
relationship
level
antihsv
neutral
antibodi
histamin
releas
investig
preliminari
experi
data
shown
reveal
exposur
leukocyt
neg
individu
uvinactiv
result
enhanc
histamin
releas
observ
inactiv
viru
capabl
enhanc
histamin
releas
nonimmun
individu
tend
exclud
immunespecif
mechan
led
us
look
possibl
role
virusinduc
interferon
supernat
fluid
leukocyt
cultur
incub
viru
control
prk
media
tabl
ii
assay
interferon
activ
supernat
fluid
control
cultur
contain
interferon
activ
contrast
five
six
case
test
supernat
fluid
cultur
expos
viru
contain
interferon
activ
rang
u
ml
except
donor
whose
leukocyt
show
increas
histamin
releas
interferon
titer
supernat
fluid
less
ml
determin
minimum
length
time
exposur
leukocyt
viru
develop
enhanc
histamin
releas
leukocyt
expos
uvinactiv
h
viral
inoculum
remov
cell
wash
incub
h
initi
exposur
viru
leukocyt
challeng
antiig
data
fig
show
signific
enhanc
histamin
releas
begin
h
exposur
cell
viru
p
effect
increas
progress
h
see
enhanc
histamin
releas
relat
presenc
interferon
supernat
fluid
collect
differ
time
assay
interferon
activ
control
cultur
less
u
ml
contrast
interferon
titer
supernat
fluid
cultur
treat
rose
u
h
ml
h
tabl
iii
show
histamin
releas
enhanc
influenza
sendai
viru
u
ml
detect
supernat
fluid
cultur
treat
influenza
sendai
viru
less
u
ml
found
supernat
fluid
cultur
treat
cultur
previou
experi
show
correl
enhanc
histamin
releas
presenc
interferon
supernat
fluid
test
whether
interferoncontain
supernat
fluid
could
transfer
capac
enhanc
histamin
releas
supernat
fluid
cultur
h
exposur
uvinactiv
prk
control
media
ad
fresh
leukocyt
interferon
titer
supernat
fluid
cultur
ml
interferon
titer
supernat
fluid
prk
control
cultur
less
ml
supernat
fluid
incub
fresh
leukocyt
h
cell
wash
challeng
ragwe
antigen
e
amount
histamin
releas
determin
data
fig
demonstr
supernat
fluid
hsvltreat
cultur
markedli
enhanc
releas
histamin
p
rule
possibl
residu
viru
rather
interferon
respons
enhanc
histamin
releas
leukocyt
cultur
stimul
nonvir
interferon
induc
cultur
expos
poli
poli
c
gml
h
wash
reincub
h
expos
ragwe
antigen
e
data
fig
b
show
treatment
poli
poli
c
leukocyt
expos
uvinactiv
virus
moi
equival
dilut
control
media
prk
media
allanto
fluid
leukocyt
challeng
nine
differ
concentr
ragwe
antigen
e
statist
analysi
entir
histamin
releas
curv
compar
util
pair
test
data
present
percent
histamin
releas
optim
ragwe
antigen
e
concentr
effect
ofdiffer
concentr
leukocyt
interferon
histamin
releas
illustr
fig
data
show
concentr
interferon
increas
capac
cell
releas
histamin
correspondingli
enhanc
statist
signific
enhanc
found
u
interferon
per
millilit
p
uml
p
see
antivir
activ
interferon
could
dissoci
factor
respons
enhanc
histamin
releas
interferon
sampl
treat
dialysi
ph
h
b
heat
min
c
trypsin
trypsin
h
treat
sampl
test
abil
enhanc
histamin
releas
antivir
activ
data
tabl
iv
show
trypsin
destroy
antivir
histamineenhanc
activ
sampl
treatment
ph
heat
fail
destroy
either
activ
sinc
interferon
known
speci
specif
effect
mous
interferon
releas
histamin
human
leukocyt
examin
fig
statist
analysi
histamin
releas
curv
pair
test
show
mous
interferon
produc
significantli
less
enhanc
histamin
releas
p
human
interferon
p
supernat
fluid
leukocyt
cultur
expos
interferon
ml
prk
control
media
interferon
ml
b
poli
poli
c
pgml
c
human
leukocyt
interferon
ml
human
fibroblast
interferon
ml
h
incub
leukocyt
challeng
ragwe
antigen
e
histamin
releas
determin
present
studi
show
incub
influenza
virus
human
peripher
blood
leukocyt
fail
releas
histamin
supernat
fluid
howev
leukocyt
cultur
first
incub
viru
challeng
ragwe
antigen
e
antiig
mark
enhanc
histamin
releas
occur
infecti
nonin
fectiou
virus
effect
examin
cultur
fluid
reveal
enhanc
histamin
releas
associ
solubl
factor
properti
interferon
sever
line
evid
indic
interferon
fact
respons
enhanc
histamin
releas
first
stimul
enhanc
histamin
releas
ie
virus
poli
poli
c
also
induc
interferon
contrast
stimul
enhanc
histamin
releas
simian
foami
viru
prk
cell
control
allanto
fluid
rpmi
medium
induc
interferon
second
direct
relationship
time
appear
amount
interferon
cultur
fluid
degre
histamin
enhanc
third
prepar
human
interferon
regardless
tissu
origin
ie
leukocyt
fibroblast
effect
control
contain
interferon
heterolog
interferon
ie
mous
ineffect
fourth
solubl
factor
respons
enhanc
histamin
releas
could
dissoci
antivir
activ
interferon
standard
physicochem
mean
whether
enhanc
histamin
releas
interferon
requir
new
rna
protein
synthesi
eg
reput
antivir
protein
interferon
present
investig
sinc
basophil
human
peripher
blood
repres
less
total
leukocyt
popul
major
virusinduc
interferon
leukocyt
cultur
almost
certainli
come
cell
type
individu
immun
particular
viru
interferon
could
nonspecif
induc
interact
viru
varieti
cell
type
eg
lymphocyt
macrophag
fibroblast
individu
immun
particular
viru
interferon
could
specif
induc
interact
viru
immun
lymphocyt
result
interferon
regardless
origin
could
act
basophil
enhanc
histamin
releas
interferon
enhanc
histamin
releas
clear
known
prepar
human
leukocyt
histamin
present
basophil
basophil
specif
receptor
ige
receptor
present
leukocyt
releas
histamin
trigger
bridg
two
ige
molecul
basophil
surfac
reaction
initi
either
ragwe
antigen
e
antiig
two
mechan
appear
ident
releas
histamin
cell
secretori
process
result
cell
death
secretori
process
modul
level
intracellular
cyclic
amp
agent
isoproterenol
prostaglandin
e
cholera
toxin
theophyllin
rais
intracellular
level
cyclic
amp
inhibit
releas
histamin
agent
either
decreas
cyclic
amp
level
eg
imidazol
aadrenerg
compound
pgf
increas
cyclic
gmp
level
eg
exogen
cyclic
gmp
carbamylcholin
report
enhanc
histamin
releas
lung
mast
cell
thu
far
peripher
basophil
microtubul
microfila
also
play
role
secretori
process
colchicin
inhibit
microtubular
aggreg
inhibit
releas
reaction
heavi
water
mani
system
promot
microtubular
aggreg
enhanc
histamin
releas
also
revers
action
colchicin
cytochalasin
b
agent
known
disrupt
microfila
also
enhanc
igemedi
histamin
releas
reaction
whether
interferon
enhanc
histamin
releas
alter
cyclic
nucleotid
level
promot
microtubul
aggreg
disrupt
microfila
mechan
remain
determin
demonstr
interferon
enhanc
histamin
releas
repres
hitherto
unrecogn
biolog
role
interferon
point
possibl
induct
interferon
may
one
cofactor
respons
precipit
potenti
attack
bronchial
asthma
viral
infect
recent
evid
sever
laboratori
indic
interferon
suppress
growth
certain
tumor
cell
alter
function
respons
cell
immun
system
review
see
refer
turn
interferon
act
common
metabol
pathway
eg
cyclic
nucleotid
microtubul
aggreg
interferon
may
modul
varieti
biolog
process
human
leukocyt
maintain
cultur
induc
releas
histamin
expos
ragwe
antigen
e
antiig
leukocyt
cultur
incub
viru
ie
influenza
expos
ragwe
antigen
e
antiig
fail
releas
histamin
howev
leukocyt
cultur
first
expos
viru
ragwe
antigen
e
antiig
signific
enhanc
histamin
releas
occur
infecti
inactiv
viru
enhanc
histamin
releas
degre
enhanc
relat
concentr
viru
length
incub
tissu
cultur
fluid
harvest
h
exposur
leukocyt
viru
contain
solubl
factor
capabl
enhanc
histamin
releas
ad
fresh
leukocyt
cultur
factor
properti
interferon
includ
speci
specif
dissoci
antivir
activ
interferon
moreov
known
induc
interferon
poli
poli
c
standard
prepar
interferon
capabl
enhanc
histamin
releas
enhanc
histamin
releas
interferon
repres
new
biolog
role
interferon
